Cargando…

Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors

The pathological processes of Alzheimer's disease and type 2 diabetes mellitus have been demonstrated to be linked together. Both PDE9 inhibitors and PPARγ agonists such as rosiglitazone exhibited remarkable preclinical and clinical treatment effects for these two diseases. In this study, a ser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xu-Nian, Huang, Ya-Dan, Li, Jin-Xuan, Yu, Yan-Fa, Qian, Zhou, Zhang, Chen, Wu, Yinuo, Luo, Hai-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089849/ https://www.ncbi.nlm.nih.gov/pubmed/30109185 http://dx.doi.org/10.1016/j.apsb.2017.12.007

Ejemplares similares

Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer’s disease
por: Zhang, Chen, et al.
Publicado: (2017)

Structure-Based Design, Synthesis, Biological Evaluation, and Molecular Docking of Novel PDE10 Inhibitors With Antioxidant Activities
por: Li, Jinxuan, et al.
Publicado: (2018)

Sulphonated graphene oxide catalyzed continuous flow synthesis of pyrazolo pyrimidinones, sildenafil and other PDE-5 inhibitors
por: Sthalam, Vinay Kumar, et al.
Publicado: (2021)

Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia
por: Wu, Xu-Nian, et al.
Publicado: (2022)

Correction: Sulphonated graphene oxide catalyzed continuous flow synthesis of pyrazolo pyrimidinones, sildenafil and other PDE-5 inhibitors
por: Sthalam, Vinay Kumar, et al.
Publicado: (2023)

Design, Synthesis, and Evaluation of Dihydropyranopyrazole Derivatives as Novel PDE2 Inhibitors for the Treatment of Alzheimer’s Disease
por: Zhou, Yan, et al.
Publicado: (2021)

Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer’s disease
por: Su, Tao, et al.
Publicado: (2016)

Computational Study on Selective PDE9 Inhibitors on PDE9-Mg/Mg, PDE9-Zn/Mg, and PDE9-Zn/Zn Systems
por: Sivakumar, Dakshinamurthy, et al.
Publicado: (2021)

Design and Microwave Assisted Synthesis of Coumarin Derivatives as PDE Inhibitors
por: Kumbar, Mahadev N., et al.
Publicado: (2016)

Design, Synthesis, In Vitro, and In Silico Studies of New N(5)-Substituted-pyrazolo[3,4-d]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors
por: Zaki, Waheed A., et al.
Publicado: (2023)

Review of Oxepine-Pyrimidinone-Ketopiperazine Type Nonribosomal Peptides
por: Guo, Yaojie, et al.
Publicado: (2020)

Green Synthesis and Urease Inhibitory Activity of Spiro-Pyrimidinethiones/Spiro-Pyrimidinones-Barbituric Acid Derivatives
por: Mohammadi Ziarani, Ghodsi, et al.
Publicado: (2015)

Regio- and stereoselective synthesis of benzothiazolo-pyrimidinones via an NHC-catalyzed Mannich/lactamization domino reaction
por: Ni, Qijian, et al.
Publicado: (2015)

Synthesis of Novel 3H-Quinazolin-4-ones Containing Pyrazolinone, Pyrazole and Pyrimidinone Moieties
por: Saleh, Mohamed A., et al.
Publicado: (2003)

Synthesis and Biological Evaluation of Benzo [4,5]- and Naphtho[2′,1′:4,5]imidazo[1,2-c]pyrimidinone Derivatives
por: Kamzeeva, Polina, et al.
Publicado: (2023)

Site-specific antitumour effects of 2 pyrimidinone compounds in rats.
por: Eggermont, A. M., et al.
Publicado: (1986)

Novel Trifluoromethyl Pyrimidinone Compounds With Activity Against Mycobacterium tuberculosis
por: Hembre, Erik, et al.
Publicado: (2021)

Synthesis and molecular modelling studies of pyrimidinones and pyrrolo[3,4-d]-pyrimidinodiones as new antiplasmodial compounds
por: Rogerio, Kamilla Rodrigues, et al.
Publicado: (2018)

Synthesis and Insecticidal Activity of Mesoionic Pyrido[1,2-α]pyrimidinone Derivatives Containing a Neonicotinoid Moiety
por: Pan, Jianke, et al.
Publicado: (2018)

Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A
por: Alexander, M S, et al.
Publicado: (2016)

Iron Oxide Nanoparticles with Supramolecular Ureido-Pyrimidinone Coating for Antimicrobial Peptide Delivery
por: Turrina, Chiara, et al.
Publicado: (2023)

Regioselective synthesis of 6-substituted-2-amino-5-bromo-4(3H)-pyrimidinones and evaluation of their antiviral activity
por: Singh, Kamaljit, et al.
Publicado: (2013)

Continuous-flow retro-Diels–Alder reaction: an efficient method for the preparation of pyrimidinone derivatives
por: Nekkaa, Imane, et al.
Publicado: (2018)

Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
por: Szczypka, Marianna
Publicado: (2020)

Synthesis and Biological Evaluation of Thieno[3,2-d]- pyrimidinones, Thieno[3,2-d]pyrimidines and Quinazolinones: Conformationally Restricted 17β-Hydroxysteroid Dehydrogenase Type 2 (17β-HSD2) Inhibitors
por: Perspicace, Enrico, et al.
Publicado: (2013)

Synthesis and in vitro cytostatic activity of new β-d-arabino furan[1′,2′:4,5]oxazolo- and arabino-pyrimidinone derivatives
por: Bosc, Jean-Jacques, et al.
Publicado: (2010)

Highly regioselective 6-exo-dig iodo/bromo cyclizations of functionalized 5-amino propargyl pyrimidinones: an efficient synthesis of functionalized pteridines
por: Naikoo, Rayees Ahmad, et al.
Publicado: (2023)

Treating COPD with PDE 4 inhibitors
por: Brown, William M
Publicado: (2007)

Identification of pyrazolopyridazinones as PDEδ inhibitors
por: Papke, Björn, et al.
Publicado: (2016)

Molecular Docking and Biophysical Studies for Antiproliferative Assessment of Synthetic Pyrazolo-Pyrimidinones Tethered with Hydrazide-Hydrazones
por: Horchani, Mabrouk, et al.
Publicado: (2021)

Experimental and computational chemical studies on the corrosion inhibition of new pyrimidinone derivatives for copper in nitric acid
por: Fouda, A. S., et al.
Publicado: (2022)

Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents
por: Afzal, Obaid, et al.
Publicado: (2022)

Design, synthesis and biological evaluation of selective survivin inhibitors
por: Xiao, Min, et al.
Publicado: (2019)

Central serous chorioretinopathy treatment with a systemic PDE5 and PDE6 inhibitor (sildenafil)
por: Coleman, D. Jackson, et al.
Publicado: (2020)

New Pyrimidinone-Fused 1,4-Naphthoquinone Derivatives Inhibit the Growth of Drug Resistant Oral Bacteria
por: Kim, Kyungmin, et al.
Publicado: (2020)

Exploring the In Situ Formation Mechanism of Polymeric Aluminum Chloride–Silica Gel Composites under Mechanical Grinding Conditions: As a High-Performance Nanocatalyst for the Synthesis of Xanthene and Pyrimidinone Compounds
por: Wang, Gang, et al.
Publicado: (2022)

Activation of PDE10 and PDE11
por: Jäger, Ronald, et al.
Publicado: (2011)

The efficacy of PDE5 inhibitors in diabetic patients
por: Swiecicka, Agnieszka
Publicado: (2022)

PDE5 inhibitor drugs for use in dementia
por: Hainsworth, Atticus H., et al.
Publicado: (2023)

Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent
por: Shao, Yong-xian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oatl8o9e4kc61m5o1vukl8qgvf